4//SEC Filing
TOMBESI PAOLO 4
Accession 0001209191-22-008985
CIK 0001595893other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 6:11 PM ET
Size
10.3 KB
Accession
0001209191-22-008985
Insider Transaction Report
Form 4
TOMBESI PAOLO
EVP & Chief Financial Officer
Transactions
- Award
Common Stock
2022-02-09+16,283→ 29,883 total - Award
Stock Option (right to buy)
2022-02-09+58,600→ 58,600 totalExercise: $37.68Exp: 2032-02-08→ Common Stock (58,600 underlying)
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
- [F2]1/48th of the shares vest monthly following February 9, 2022.
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001707648
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 6:11 PM ET
- Size
- 10.3 KB